New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 4, 2014
08:26 EDTESRX, WLPWellPoint price target raised to $130 from $120 at Leerink
Leerink believes WellPoint (WLP) has "strong negotiating leverage" against Express Scripts (ESRX) over the 10-year contract between the two companies. Leerink thinks the contract could be renewed early under more favorable rates for WellPoint. The firm raised its price target for shares to $130 and keeps an Outperform rating on the stock. Leerink also raised its price target for Express Scripts shares to $85 from $80.
News For WLP;ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2015
07:45 EDTESRXExpress Scripts appears to be gaining momentum, says RBC Capital
Subscribe for More Information
July 28, 2015
19:10 EDTESRXOn The Fly: After Hours Movers
Subscribe for More Information
16:18 EDTESRXExpress Scripts up 2.6% after reporting Q2 results, guidance
Subscribe for More Information
16:18 EDTESRXExpress Scripts sees FY16 adjusted claims 1.26B-1.3B
Subscribe for More Information
16:17 EDTESRXExpress Scripts sees retention rate for FY15 selling season 95%-97%
Subscribe for More Information
16:15 EDTESRXExpress Scripts reports Q2 adjusted claims down 1% to 321.2M
Subscribe for More Information
16:14 EDTESRXExpress Scripts raises FY15 EPS view to $5.46-$5.54 from $5.37-$5.47
Subscribe for More Information
16:13 EDTESRXExpress Scripts sees Q3 adjusted EPS $1.41-$1.45, consensus $1.43
Subscribe for More Information
16:11 EDTESRXExpress Scripts reports Q2 adjusted EPS $1.44, consensus $1.40
Subscribe for More Information
15:21 EDTESRXNotable companies reporting after market close
Subscribe for More Information
July 22, 2015
05:22 EDTESRXStocks with implied volatility movement; LOCK ESRX
Subscribe for More Information
July 21, 2015
12:39 EDTESRXCiti analyzes a potential Express Scripts takeout by Walgreens Boots Alliance
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use